Thorac Cardiovasc Surg 2019; 67(S 01): S1-S100
DOI: 10.1055/s-0039-1678890
Oral Presentations
Monday, February 18, 2019
DGTHG: Aortenklappe II
Georg Thieme Verlag KG Stuttgart · New York

Incidence of new Permanent Pacemaker Implantation after Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Implantation and Its Impact on 1-Year Mortality—Insights from the German Aortic Valve Registry

B. Fujita
1   Department of Heart and Thoracic Vascular Surgery, University of Schleswig-Holstein, Lübeck Campus, Lübeck, Germany
,
T. Schmidt
2   Asklepios Klinik St. Georg, Hamburg, Germany
,
S. Bleiziffer
3   German Heart Center Munich, München, Germany
,
T. Bauer
4   Universität Gießen, Gießen, Germany
,
A. Beckmann
5   Deutsche Gesellschaft für Thorax-, Herz- und Gefäßchirurgie, Berlin, Germany
,
R. Bekeredjian
6   Robert-Bosch-Krankenhaus, Stuttgart, Germany
,
H. Möllmann
7   St. Johannes Hospital, Dortmund, Germany
,
T. Walther
8   Universität Frankfurt, Frankfurt, Germany
,
S. Landwehr
9   BQS Institut für Qualität und Patientensicherheit, Düsseldorf, Germany
,
C. Hamm
10   Kerckhoff-Heart Center Bad Nauheim, Bad Nauheim, Germany
,
F. Beyersdorf
11   Universitäts Herzzentrum - Freiburg/Bad Krozingen, Freiburg, Germany
,
H. Katus
12   Universität Heidelberg, Heidelberg, Germany
,
W. Harringer
13   Klinikum Braunschweig, Braunschweig, Germany
,
S. Ensminger
1   Department of Heart and Thoracic Vascular Surgery, University of Schleswig-Holstein, Lübeck Campus, Lübeck, Germany
,
C. Frerker
2   Asklepios Klinik St. Georg, Hamburg, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
28 January 2019 (online)

   All articles of this category

Objectives: The aim of this analysis was to evaluate the incidence of new permanent pacemaker implantation (NPMI) after surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) and investigate its influence on 1-year mortality.

Methods: Patients who were enrolled in the German Aortic Valve Registry (GARY) undergoing isolated SAVR or TAVI between 2011 and 2015 were analyzed. The rate of NPMI was analyzed for both groups and multivariable Cox regression analysis was performed to investigate the possible independent association between NPMI and 1-year survival.

Results: A total of 17,750 patients who underwent SAVR and 20,872 patients who received TAVI were included in this study. The rate of NPMI was 3.6% after SAVR and 16.6% after TAVI. In the SAVR group, NPMI significantly increased 1-year mortality in univariable analysis (HR 1.55 [95% CI 1.08–2.22], p = 0.02), while after multivariable adjustment, NPMI did not emerge as an independent risk factor (HR 1.29 [0.88–1.89], p = 0.19). In the TAVI group, NPMI was associated with an increased risk for 1-year mortality in univariable analysis as well (HR 1.29 [1.18–1.41], p < 0.001). This association persisted after multivariable adjustment (HR 1.29 [1.16–1.43], p < 0.001). A 30-day mortality was not affected by NPMI in both procedure groups.

Conclusion: The need for NPMI was markedly higher after TAVI compared with SAVR and was independently associated with increased 1-year mortality after TAVI but not after SAVR. As 30-day mortality was not affected by NPMI, the additional procedure of NPMI does not seem to be responsible for this finding. Further research is necessary to investigate underlying mechanisms.